<DOC>
	<DOCNO>NCT00274326</DOCNO>
	<brief_summary>Primary : - To assess efficacy SR121463B correct hyponatremia patient dilutional hyponatremia SIADH cirrhosis Secondary : - To assess long-term efficacy SR121463B maintain normonatremia patient - To assess safety tolerability SR121463B</brief_summary>
	<brief_title>DILIPO ( DILutIonal HyPOnatremia )</brief_title>
	<detailed_description>SR121463B orally effective non-peptide , potent , highly selective V2 receptor antagonist cause free water elimination animal human</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Satavaptan</mesh_term>
	<criteria>Male Female patient age 18 high Dilutional Hyponatremia serum sodium 115 132 mmol/L Ability give write informed consent ( informed consent may sign legally authorize representative patient unable sign ) Presence know untreated adrenal insufficiency , SIADH cirrhosis , hyperthyroidism Presence sign hypovolemia Administration V2 receptor antagonist demeclocycline lithium within one month urea within two day prior study drug administration Presence uncontrolled diabetes fast glycemia ³ 200 mg/dL ( ³ 11.09 mmol/L ) Patients consider Investigator unsuitable candidate receive investigational drug ( e.g. , presence neurological symptom may worsen five day , base judgment Investigator , presence neurological symptom persistence hyponatremia several day may deleterious ) Administration inducer CYP3A4 ( phenobarbital , phenytoin , rifampin , Saint John 's Wort ) potent moderate inhibitor CYP3A4 within two week prior study drug administration Presence history allergic reaction SR121463B8 Previous study SR121463B Inadequate hematological , renal , hepatic function : hemoglobin ( Hb ) &lt; 9 g/dL , neutrophils &lt; 1,500/mm3 , platelet &lt; 100,000/mm3 , serum creatinine &gt; 175 mol/L ( clearance creatinine &lt; 30 mL/min site Ethics Committees require parameter ) , serum alanine aminotransferase ( ALT ) and/or aspartate aminotransferase ( AST ) &gt; 2 x upper limit normal ( ULN ) QTCB 500 ³ m Positive pregnancy test absence medically approve contraceptive method ( e.g. , surgical sterilization one month duration , oral contraception intrauterine device combination either diaphragm , condom , spermicide ) females childbearing potential Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Hyponatremia</keyword>
</DOC>